Actos for Hypothyroidism Treatment

Thursday, October 3rd, 2013

A recent study suggest that pioglitazone (Actos) along with levothyroxine may reduce thyroid stimulating hormone levels and improve resistance to insulin in patients suffering from hypothyroidism. This crossover study involves 8 men and 17 women diagnosed with overt hypothyroidism and insulin resistance, but not diabetes. A second-line combination treatment with levothyroxine and pioglitazone was prescribed […]

Linagliptin Better than Actos

Wednesday, October 2nd, 2013

Patients diagnosed with type 2 diabetes often have to take multiple medications to keep their blood sugar levels in check, along with long-acting insulin doses. A new study shows that linagliptin may be a better option than some other medications generally recommended to patients, like pioglitazone (Actos). The study shows that adding linagliptin to the […]

Lawsuit against Actos in Maryland

Wednesday, September 18th, 2013

A collective lawsuit against Takeda Pharmaceuticals’ diabetes drug Actos is now underway in Baltimore, Maryland. The complainants’ attorney state in court that Takeda Pharma did not warn patients taking Actos about its bladder cancer risks. The trial, which is being held in State Court, is one of the 3,000 other cases against Takeda Pharma over […]

Actos Ban Lifted in Most States in India, but Continues in Two

Tuesday, September 17th, 2013

The Drug Controller General of India (DGCI) withdrew the suspension on pioglitazone (Actos) on September 1, 2013. Despite the withdraw on the medications manufacture and sale, it is still not being sold in two state- Tamil Nadu and Maharashtra. Orissa was another state that did not sell these medications, but pharmacies across the state began […]